Trospium Chloride Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Trospium Chloride Tablets contain NLT 90.0% and NMT 110.0% of the labeled amount of trospium chloride (C25H30CINO3).
2 IDENTIFICATION
A. The retention time and UV spectrum of the major peak of the Sample solution correspond to those of the major peak of the Standard solution, as obtained in the Assay.
3 ASSAY
PROCEDURE
Mobile phase: Acetonitrile, triethylamine, phosphoric acid, and water (350:1:3:650)
Standard solution: 0.1 mg/mL of USP Trospium Chloride RS in Mobile phase
Sample solution: Weigh and finely powder NLT 20 Tablets. Transfer a portion of the powder, equivalent to 100 mg of trospium chloride, to a 100-mL volumetric flask. Add 75 ml of Mobile phase, and sonicate for about 30 min. Dilute with Mobile phase to volume. Further dilute with Mobile phase to obtain a solution having a nominal concentration of 0.1 mg/mL of trospium chloride. Pass through a suitable filter of 0.45-um pore size, and use the filtrate.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 4.6-mm x 25-cm; 5-µm packing 11
Flow rate: 1.0 mL/min
Column temperature: 40o
Injection volume: 20 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of trospium chloride (C25H30CINO3) in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of trospium chloride from the Sample solution
rs = peak response of trospium chloride from the Standard solution
Cs = concentration of USP Trospium Chloride RS in the Standard solution (mg/mL)
Cu = nominal concentration of trospium chloride in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 PERFORMANCE TESTS
Change to read:
DISSOLUTION (711)
Test 1
Medium: 0.1 N hydrochloric acid: 1000 mL
Apparatus 2: 50 rpm
Time: 30 min
Mobile phase: Acetonitrile, triethylamine, phosphoric acid, and water (350:13:650)
Standard stock solution: 0.5 mg/mL of USP Trospium Chloride RS in Mobile phase
Standard solution: 0.02 mg/mL in Medium from the Standard stock solution.
Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-µm pore size.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Flow rate: 1.0 mL/min
Column temperature: 40o
Injection volume: 50 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of trospium chloride (C25H30CINO3) dissolved:
Result = (ru /rs ) × (Cs /L) × V × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of the Standard solution (mg/mL)
L = label claim (mg/Tablet)
V = volume of Medium, 1000 mL
Tolerances: NLT 80% (Q) of the labeled amount of trospium chloride is dissolved.
Test 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 0.1 N hydrochloric acid; 1000 mL
Apparatus 2: 50 rpm
Time: 30 min
Mobile phase: Acetonitrile, triethylamine, phosphoric acid, and water (300:1:3:700)
Standard stock solution: 0.2 mg/mL of USP Trospium Chloride RS in Medium
Standard solution: 0.02 mg/mL in Medium from the Standard stock solution
Sample solution: Pass a portion of the solution under test through a suitable lter of 0.45-µm pore size.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 215 nm
Columns
Guard: 4.0-mm × 4-cm; 5-µm packing L7
Analytical: 4.0-mm × 12.5-cm; 4-µm packing L7
Flow rate: 1.0 mL/min
Column temperature: 40°
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of trospium chloride (C25H30CINO3) dissolved:
Result = (ru /rs ) × (Cs /L)× V × 100
ru = peak response from the Sample solution
rs = peak response from the Standard solution
Cs = concentration of the Standard solution (mg/mL)
L = label claim (mg/Tablet)
V = volume of Medium, 1000 mL
Tolerances: NLT 75% (Q) of the labeled amount of trospium chloride is dissolved.
Test 3: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3.
Medium: 0.1 N hydrochloric acid: 500 mL
Apparatus 2: 50 rpm
Time: 30 min
Mobile phase: Acetonitrile, triethylamine, phosphoric acid, and water (35: 0.1:0.3:65)
Standard stock solution: 0.5 mg/mL of USP Trospium Chloride RS in Medium, Sonicate to dissolve, if necessary.
Standard solution: 0.04 mg/ml. of USP Trospium Chloride RS from the Standard stock solution in Medium
Sample solution: Pass the portion of the solution under test through a suitable filter of 0.45-µm pore size, discarding an appropriate volume of filtrate so that a consistent result can be obtained.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm.
Column: 4.6-mm x 25-cm; 5-µm packing L1
Column temperature: 40°
Flow rate: 1.0 mL/min
Injection volume: 50 µL
Run time: NLT 1.8 times the
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of trospium chloride (C25H30CINO3) dissolved:
Result = (ru /rs ) × Cs × (1/L) × V × 100
ru = peak response of trospium from the Sample solution
rs = peak response of trospium from the Standard solution
Css = concentration of USP Trospium Chloride RS in the Standard solution (mg/mL)
L = label claim (mg/Tablet)
V = volume of Medium, 500 mL
Tolerances: NLT 80% (Q) of the labeled amount of trospium chloride is dissolved. (RB 1-Jan-2025)
Uniformity of Dosage Units 〈905〉: Meet the requirements
5 IMPURITIES
ORGANIC IMPURITIES
Mobile phase: Acetonitrile, triethylamine, phosphoric acid, and water (300:1:3:700)
System suitability solution: 0.01 mg/mL of USP Trospium Chloride RS. 0.003 mg/mL of USP Trospium Chloride Related Compound A RS, and 0.015 mg/mL of USP Trospium Chloride Related Compound B RS in Mobile phase
Standard solution: 0.003 mg/ml of USP Trospium Chloride RS in Mobile phase
Sample solution: Finely powder NLT 20 Tablets. Transfer a portion of the powder, equivalent to 150 mg of trospium chloride, to a 50-mL volumetric flask. Add 30 mL of Mobile phase, and sonicate for about 30 min. Dilute with Mobile phase to volume. Pass through a suitable filter of 0.45-µm pore size, and use the filtrate.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 4.6-mm x 25-cm; 5-µm packing L7
Flow rate: 1.0 mL/min
Column temperature: 40°
Injection volume: 20 µL
System suitability
Samples: System suitability solution and Standard solution
Suitability requirements
Resolution: NLT 3 between trospium chloride related compound B and trospium, System suitability solution
Relative standard deviation: NMT 5%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of any impurity in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × (1/F) × 100
ru = peak response of each individual impurity from the Sample solution
rs = peak response of trospium chloride from the Standard solution
Cs = concentration of USP Trospium Chloride RS in the Standard solution (mg/mL)
Cu = nominal concentration of trospium chloride in the Sample solution (mg/mL)
F = relative response factor (see Table 1)
Acceptance criteria: See Table 1.
Table 1
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Nortropane benzilate (trospium chloride related compound B) | 0.7 | 1.0 | 0.2 |
| Trospium | 1.0 | - | - |
| Benzilic acid (trospium chloride related compound A) | 1.9 | 1.7 | 0.2 |
| Any other individual impurity | - | 1.0 | 0.1 |
| Total impurities | - | - | 0.5 |
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight containers, protected from light. Store at controlled room temperature.
Labeling: When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
USP Reference Standards 〈11〉
USP Trospium Chloride RS
USP Trospium Chloride Related Compound A RS
Benzilic acid.
C14H12O3 228.24 CAS RN: 76-93-7.
USP Trospium Chloride Related Compound B RS
Nortropane benzilate; (1R,3r,5S)-8-azabicyclo [3.2.1]octan-3-yl hydroxydiphenylacetate.
C21H23NO3 337.41

